Table 1.

Patient demographics, clinicopathological, and survival data for the 74 patients with colorectal cancer included in this study.

Clinicopathological Parameter	Patients with Colorectal Cancer (N = 74)
Mean age (±SD, range)	67.8 years (±12.5, 38–90 years)
Gender Male Female	51 (68.9%) 23 (31.1%)
Tumour Location Colon Rectum	52 (70.3%) 22 (29.7%)
Presentation Emergency Elective	12 (16.2%) 62 (83.8%)
Histological subtype Adenocarcinoma Mucinous Other/Missing	53 (68.0%) 3 (3.8%) 22 (28.2)
Tumour Stage T1 T2 T3 T4 TX	2 (2.7%) 5 (6.8%) 25 (33.8%) 18 (24.3%) 24 (32.4%)
Nodal Stage N0 N1 N2 NX	15 (20.3%) 20 (27.0%) 10 (13.5%) 29 (39.2%)
Chemotherapy Received NAC Received AC Did not receive/Unknown	12 (16.2%) 40 (54.1%) 22 (29.7%)
Recurrence Recurrence No Recurrence	18 (24.3%) 56 (75.7%)
Recurrence Location Liver Lung Adrenal Liver and Lung Adrenal and Liver Mediastinum Pelvis None	7 (9.0%) 3 (3.9%) 2 (2.6%) 1 (1.3%) 1 (1.3%) 1 (1.3%) 3 (3.9%) 56 (75.7%)
Survival Alive RIP	43 (58.1%) 31 (41.9%)
5-Year DFS	51/74 (68.9%)
5-Year OS	53/74 (71.6%)

SD—standard deviation, NAC—neoadjuvant chemotherapy, AC—adjuvant chemotherapy, RIP—rest in peace, DFS—disease-free survival, OS—overall survival.